Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions
<Bundle xmlns="http://hl7.org/fhir">
<id value="bundle-processed-pt-2d49ae46735143c1323423b7aea24165"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi"/>
</meta>
<language value="pt"/>
<identifier>
<system value="https://www.gravitatehealth.eu/sid/doc"/>
<value value="EU/1/97/049/001-pt"/>
</identifier>
<type value="document"/>
<timestamp value="2023-06-27T10:09:22Z"/>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-processed-pt-f4d45353edcb21af3718d3a0df94a4d8"/>
<resource>
<Composition>
<id
value="composition-processed-pt-f4d45353edcb21af3718d3a0df94a4d8"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi"/>
</meta>
<language value="pt"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml" xml:lang="pt" lang="pt"><a name="Composition_composition-processed-pt-f4d45353edcb21af3718d3a0df94a4d8"> </a><p><b>Generated Narrative: Composition</b><a name="composition-processed-pt-f4d45353edcb21af3718d3a0df94a4d8"> </a><a name="hccomposition-processed-pt-f4d45353edcb21af3718d3a0df94a4d8"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceComposition "composition-processed-pt-f4d45353edcb21af3718d3a0df94a4d8" (Language "pt") </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Composition-uv-epi.html">Composition (ePI)</a></p></div><blockquote><p><b>HtmlElementLink</b></p><blockquote><p><b>url</b></p><code>elementClass</code></blockquote><p><b>value</b>: pregnancyCategory</p><blockquote><p><b>url</b></p><code>concept</code></blockquote><p><b>value</b>: Pregnancy <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOWMED CT</a>#77386006)</span></p></blockquote><blockquote><p><b>HtmlElementLink</b></p><blockquote><p><b>url</b></p><code>elementClass</code></blockquote><p><b>value</b>: breastfeedingCategory</p><blockquote><p><b>url</b></p><code>concept</code></blockquote><p><b>value</b>: Normal breast feeding (finding) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOWMED CT</a>#69840006)</span></p></blockquote><blockquote><p><b>HtmlElementLink</b></p><blockquote><p><b>url</b></p><code>elementClass</code></blockquote><p><b>value</b>: indication</p><blockquote><p><b>url</b></p><code>concept</code></blockquote><p><b>value</b>: ClinicalUseDefinition/cud-585e364c14debe29f6c6b564138aa400</p></blockquote><blockquote><p><b>HtmlElementLink</b></p><blockquote><p><b>url</b></p><code>elementClass</code></blockquote><p><b>value</b>: contraindication</p><blockquote><p><b>url</b></p><code>concept</code></blockquote><p><b>value</b>: Contraindicated (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOWMED CT</a>#410536001)</span></p></blockquote><blockquote><p><b>HtmlElementLink</b></p><blockquote><p><b>url</b></p><code>elementClass</code></blockquote><p><b>value</b>: contra-indication-pregnancy</p><blockquote><p><b>url</b></p><code>concept</code></blockquote><p><b>value</b>: ClinicalUseDefinition/contraindication-pregnancy</p></blockquote><blockquote><p><b>HtmlElementLink</b></p><blockquote><p><b>url</b></p><code>elementClass</code></blockquote><p><b>value</b>: contra-indication-kidney</p><blockquote><p><b>url</b></p><code>concept</code></blockquote><p><b>value</b>: ClinicalUseDefinition/contraindication-kidney</p></blockquote><blockquote><p><b>HtmlElementLink</b></p><blockquote><p><b>url</b></p><code>elementClass</code></blockquote><p><b>value</b>: contra-indication-diabetes-mellitus</p><blockquote><p><b>url</b></p><code>concept</code></blockquote><p><b>value</b>: ClinicalUseDefinition/contraindication-diabetes-mellitus</p></blockquote><blockquote><p><b>HtmlElementLink</b></p><blockquote><p><b>url</b></p><code>elementClass</code></blockquote><p><b>value</b>: lactose</p><blockquote><p><b>url</b></p><code>concept</code></blockquote><p><b>value</b>: Primary lactose intolerance <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOWMED CT</a>#190751001)</span></p></blockquote><p><b>identifier</b>: <code>https://spor.ema.europa.eu/rmswi/</code>/karvea-pt-processed</p><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000155538)</span></p><p><b>category</b>: Processed <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-epicategory-cs.html">Category of EPI</a>#P)</span></p><p><b>date</b>: 2022-02-16 13:28:17+0000</p><p><b>author</b>: See on this page: Organization/mah-511671db37e83e520b00f8a0d817dc96</p><p><b>title</b>: TEST PURPOSES ONLY - Karvea</p><h3>Attesters</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Mode</b></td><td><b>Time</b></td></tr><tr><td style="display: none">*</td><td>Official <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-composition-attestation-mode.html">Composition Attestation Mode</a>#official)</span></td><td>2022-02-16 13:28:17+0000</td></tr></table></div>
</text>
<extension
url="http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/HtmlElementLink">
<extension url="elementClass">
<valueString value="pregnancyCategory"/>
</extension>
<extension url="concept">
<valueCodeableReference>
<concept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="77386006"/>
<display value="Pregnancy"/>
</coding>
</concept>
</valueCodeableReference>
</extension>
</extension>
<extension
url="http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/HtmlElementLink">
<extension url="elementClass">
<valueString value="breastfeedingCategory"/>
</extension>
<extension url="concept">
<valueCodeableReference>
<concept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="69840006"/>
<display value="Normal breast feeding (finding)"/>
</coding>
</concept>
</valueCodeableReference>
</extension>
</extension>
<extension
url="http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/HtmlElementLink">
<extension url="elementClass">
<valueString value="indication"/>
</extension>
<extension url="concept">
<valueCodeableReference>
<reference>
<reference
value="ClinicalUseDefinition/cud-585e364c14debe29f6c6b564138aa400"/>
</reference>
</valueCodeableReference>
</extension>
</extension>
<extension
url="http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/HtmlElementLink">
<extension url="elementClass">
<valueString value="contraindication"/>
</extension>
<extension url="concept">
<valueCodeableReference>
<concept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="410536001"/>
<display value="Contraindicated (qualifier value)"/>
</coding>
</concept>
</valueCodeableReference>
</extension>
</extension>
<extension
url="http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/HtmlElementLink">
<extension url="elementClass">
<valueString value="contra-indication-pregnancy"/>
</extension>
<extension url="concept">
<valueCodeableReference>
<reference>
<reference
value="ClinicalUseDefinition/contraindication-pregnancy"/>
</reference>
</valueCodeableReference>
</extension>
</extension>
<extension
url="http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/HtmlElementLink">
<extension url="elementClass">
<valueString value="contra-indication-kidney"/>
</extension>
<extension url="concept">
<valueCodeableReference>
<reference>
<reference
value="ClinicalUseDefinition/contraindication-kidney"/>
</reference>
</valueCodeableReference>
</extension>
</extension>
<extension
url="http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/HtmlElementLink">
<extension url="elementClass">
<valueString value="contra-indication-diabetes-mellitus"/>
</extension>
<extension url="concept">
<valueCodeableReference>
<reference>
<reference
value="ClinicalUseDefinition/contraindication-diabetes-mellitus"/>
</reference>
</valueCodeableReference>
</extension>
</extension>
<extension
url="http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/HtmlElementLink">
<extension url="elementClass">
<valueString value="lactose"/>
</extension>
<extension url="concept">
<valueCodeableReference>
<concept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="190751001"/>
<display value="Primary lactose intolerance"/>
</coding>
</concept>
</valueCodeableReference>
</extension>
</extension>
<identifier>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<value value="karvea-pt-processed"/>
</identifier>
<status value="final"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="Package Leaflet"/>
</type>
<category>
<coding>
<system
value="http://hl7.eu/fhir/ig/gravitate-health/CodeSystem/epicategory-cs"/>
<code value="P"/>
<display value="Processed"/>
</coding>
</category>
<subject>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</subject>
<date value="2022-02-16T13:28:17Z"/>
<author>
<reference
value="Organization/mah-511671db37e83e520b00f8a0d817dc96"/>
</author>
<title value="TEST PURPOSES ONLY - Karvea"/>
<attester>
<mode>
<coding>
<system
value="http://hl7.org/fhir/composition-attestation-mode"/>
<code value="official"/>
</coding>
</mode>
<time value="2022-02-16T13:28:17Z"/>
</attester>
<section>
<title value="B. Package Leaflet"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="B. PACKAGE LEAFLET"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">unavailable</div>
</text>
<emptyReason>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/list-empty-reason"/>
<code value="unavailable"/>
</coding>
</emptyReason>
<section>
<title value="Package leaflet: Information for the user"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="Package leaflet: Information for the user"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>Karvea 300 mg comprimidos</p><p>irbesartan</p><p>Leia com atenção todo este folheto antes de começar a tomar este medicamento, pois contém informação importante para si.</p><ul><li>Conserve este folheto. Pode ter necessidade de o ler novamente.</li><li>Caso ainda tenha dúvidas, fale com o seu médico ou farmacêutico.</li><li>Este medicamento foi receitado apenas para si. Não deve dá-lo a outros; o medicamento pode serlhes prejudicial mesmo que apresentem os mesmos sinais de doença.</li><li>Se tiver quaisquer efeitos secundários, incluindo efeitos secundários não indicados neste folheto, fale com o seu médico ou farmacêutico.</li></ul></div>
</text>
</section>
<section>
<title value="What is in this leaflet"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="What is in this leaflet"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><strong>O que contém este folheto:</strong></p><ol><li>O que é Karvea e para que é utilizado</li><li>O que precisa de saber antes de tomar Karvea</li><li>Como tomar Karvea</li><li>Efeitos secundários possíveis</li><li>Como conservar Karvea</li><li>Conteúdo da embalagem e outras informações</li></ol></div>
</text>
</section>
<section>
<title value="1. What Karvea is and what it is used for"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="1. What Karvea is and what it is used for"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>Karvea pertence a um grupo de medicamentos conhecidos como antagonistas dos recetores da angiotensina-II. A angiotensina-II é uma substância produzida no organismo que se liga a recetores nos vasos sanguíneos, provocando o seu estreitamento, o que conduz ao aumento da pressão arterial. Karvea impede a ligação da angiotensina-II a estes recetores, fazendo com que os vasos sanguíneos se relaxem e a pressão arterial baixe. Karvea atrasa a diminuição da função renal nos doentes com pressão arterial elevada e diabetes do tipo 2.</p><div class="indication"><p>Karvea é usado em doentes adultos</p><ul><li>para tratar a pressão arterial elevada (hipertensão essencial)</li><li>para proteger os rins nos doentes com pressão arterial elevada, diabetes do tipo 2 e evidência laboratorial de insuficiência dos rins.</li></ul></div></div>
</text>
</section>
<section>
<title value="2. What you need to know before you take Karvea"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="2. What you need to know before you take Karvea"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><strong>Não tome Karvea</strong></p><ul><li>se tem alergia ao irbesartan ou a qualquer outro componente deste medicamento (indicados na secção 6).</li><li class="contra-indication-pregnancy">se tiver mais do que três meses de gravidez. (Também é preferível não tomar Karvea no início da gravidez - ver secção Gravidez</li><li><span class="contra-indication-diabetes-mellitus">se tem diabetes </span>ou <span class="contra-indication-kidney">função renal diminuída</span> e está a ser tratado com um medicamento que contém aliscireno para diminuir a pressão arterial</li></ul><p><strong>Advertências e precauções</strong></p><p>Fale com o seu médico antes de tomar Karvea e se alguma das seguintes situações se aplicar a si:</p><ul><li>se tiver vómitos ou diarreia prolongados</li><li>se sofrer de problemas nos rins</li><li>se sofre de problemas do coração</li><li>se receber Karvea para doença nos rins diabética. Neste caso, o seu médico pode efetuar-lhe análises ao sangue com regularidade, especialmente para medir os níveis sanguíneos de potássio em caso de insuficiência dos rins se desenvolver baixos níveis de açúcar no sangue (os sintomas podem incluir sudação, fraqueza, fome, tonturas, tremores, dor de cabeça, rubor ou palidez, dormência, batimento cardíaco acelerado e palpitante), especialmente se estiver a ser tratado para a diabetes.</li><li>se vai ser submetido a uma operação (cirurgia) ou se lhe vão ser administrados anestésicos</li><li>se está a tomar algum dos seguintes medicamentos para tratar a pressão arterial elevada:<ul><li>um inibidor da ECA (por exemplo enalapril, lisinopril, ramipril), em particular se tiver problemas nos rins relacionados com diabetes.</li><li>aliscireno</li></ul></li></ul><p>O seu médico pode verificar a sua função renal, pressão arterial e a quantidade de eletrólitos (por exemplo, o potássio) no seu sangue em intervalos regulares.</p><p>Ver também a informação sob o título “Não tome Karvea”</p><p>Deve informar o seu médico se pensa que está (ou pode vir a estar) grávida. Karvea não está recomendado no início da gravidez e não pode ser tomado após o terceiro mês de gravidez, uma vez que pode ser gravemente prejudicial para o bebé se utilizado a partir desta altura (ver secção Gravidez).</p><p><strong>Crianças e adolescentes</strong></p><p>Este medicamento não deve ser utilizado em crianças e adolescentes uma vez que não foram ainda completamente estabelecidas a segurança e eficácia.</p><p><strong>Outros medicamentos e Karvea</strong></p><p>Informe o seu médico ou farmacêutico se estiver a tomar, tiver tomado ou se vier a tomar outros medicamentos. O seu médico pode precisar de alterar a dose e/ou tomar outras precauções se estiver a tomar aliscireno. Se está a tomar um inibidor da ECA ou aliscireno (ver também informações sob os títulos “Não tome Karvea” e “Advertências e precauções”).</p><p><strong>Poderá necessitar de fazer algumas verificações ao sangue caso tome:</strong></p><ul><li>suplementos de potássio</li><li>substitutos de sal contendo potássio</li><li>medicamentos poupadores de potássio (como sejam alguns diuréticos)</li><li>medicamentos contendo lítio</li><li>repaglinida (medicamento utilizado para baixar os níveis de açúcar no sangue)</li></ul><p>Se tomar alguns medicamentos para as dores, denominados anti-inflamatórios não-esteroides, o efeito do irbesartan poderá ser reduzido.</p><p><strong>Karvea com alimentos e bebidas</strong></p><p>Karvea pode ser tomado com ou sem alimentos.</p><div class="pregnancyCategory"><p><strong>Gravidez e amamentação</strong></p><p><strong>Gravidez</strong></p><p>Deve informar o seu médico se pensa que está (ou pode vir a estar) grávida. O seu médico normalmente aconselha-la-á a interromper Karvea antes de engravidar ou assim que estiver grávida e a tomar outro medicamento em vez de Karvea. Karvea não está recomendado no início da gravidez e não pode ser tomado após o terceiro mês de gravidez, uma vez que pode ser gravemente prejudicial para o bebé se utilizado a partir desta altura.</p></div><div class="breastfeedingCategory"><p><strong>Amamentação</strong></p><p>Deverá informar o seu médico de que se encontra a amamentar ou que está prestes a iniciar o aleitamento. Karvea não está recomendado em mães a amamentar, especialmente se o bebé for recémnascido ou prematuro; nestes casos o seu médico poderá indicar outro tratamento.</p></div><p><strong>Condução de veículos e utilização de máquinas</strong></p><p>Não é provável que Karvea afete a sua capacidade de conduzir e usar máquinas. Contudo, ocasionalmente, podem ocorrer tonturas ou fadiga durante o tratamento da hipertensão. Se sentir estes efeitos, fale com o seu médico antes de tentar conduzir ou utilizar máquinas.</p><p><strong><span class="lactose">Karvea contém lactose.</span> </strong>Se foi informado pelo seu médico de que é intolerante a alguns açúcares (por exemplo, a lactose), deverá contactá-lo antes de tomar este medicamento.</p><p><strong>Karvea contém sódio.</strong> Este medicamento contém menos de 1 mmol de sódio (23 mg) por comprimido, ou seja, é praticamente 'isento de sódio'.</p></div>
</text>
</section>
<section>
<title value="3. How to take Karvea"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="3. How to take Karvea"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>Tomar este medicamento exatamente como indicado pelo seu médico. Fale com o seu médico ou farmacêutico se tiver dúvidas.</p><p><strong>Modo de administração</strong></p><p>Karvea destina-se à via oral. Engolir os comprimidos com uma quantidade suficiente de líquidos (por exemplo um copo com água). Pode tomar Karvea com ou sem alimentos. Tente tomar a dose diária sempre à mesma hora. É importante que continue a tomar Karvea até que o seu médico lhe dê outra indicação.</p><ul><li>Doentes com pressão arterial elevada</li></ul><p>A dose habitual é 150 mg uma vez ao dia. Em função da resposta da pressão arterial, a dose pode ser aumentada para 300 mg, uma vez ao dia.</p><ul><li>Doentes com pressão arterial elevada e diabetes do tipo 2 com doença nos rins</li></ul><p>Nos doentes com pressão arterial elevada e diabetes do tipo 2, a dose de manutenção preferível para o tratamento da doença renal associada é de 300 mg uma vez por dia.</p><p>O médico pode receitar uma dose mais baixa, sobretudo quando se inicia o tratamento em certos doentes, como sejam os que estão em hemodiálise ou os que têm mais de 75 anos.</p><p>O efeito hipotensor máximo deve obter-se às 4 a 6 semanas após o início do tratamento.</p><p><strong>Utilização em crianças e adolescentes</strong></p><p>Karvea não deve ser administrado a crianças com idade idade inferior a 18 anos. Se uma criança engolir alguns comprimidos, deve contactar o médico imediatamente.</p><p><strong>Se tomar mais Karvea do que deveria</strong></p><p>Se, acidentalmente, tomar demasiados comprimidos, contacte o médico imediatamente. Caso se tenha esquecido de tomar Karvea Se, acidentalmente, não tomar uma dose diária, tome a dose seguinte como planeado. Não tome uma dose a dobrar para compensar uma dose que se esqueceu de tomar.</p><p>Caso ainda tenha dúvidas sobre a utilização deste medicamento, fale com o seu médico ou farmacêutico.</p></div>
</text>
</section>
<section>
<title value="4. Possible side effects"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="4. Possible side effects"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>Como todos os medicamentos, este medicamento pode causar efeitos secundários, embora estes não se manifestem em todas as pessoas. Alguns destes efeitos podem ser graves e requerer cuidados médicos.</p><p>Tal como acontece com medicamentos semelhantes, em doentes a tomar irbesartan foram notificados casos raros de reações alérgicas na pele (erupção na pele, erupção na pele com comichão), assim como inchaço localizado da face, lábios e/ou língua. Se tiver algum destes sintomas, ou se tiver dificuldade em respirar, <strong>pare de tomar Karvea e contacte o médico imediatamente.</strong></p><p>A frequência dos efeitos adversos listados abaixo é definida utilizando a seguinte convenção:</p><p>Muito frequentes: podem afetar mais de 1 em 10 pessoas</p><p>Frequentes: podem afetar até 1 em 10 pessoas</p><p>Pouco frequentes: podem afetar até 1 em 100 pessoas</p><p>Os efeitos secundários notificados em estudos clínicos para os doentes tratados com Karvea foram:</p><ul><li>Muito frequentes (podem afetar mais de 1 em 10 pessoas): se tiver pressão arterial elevada e diabetes do tipo 2 com doença nos rins, as análises ao sangue podem mostrar níveis de potássio aumentados.</li><li>Frequentes (podem afetar até 1 em 10 pessoas): tonturas, mal estar/vómitos, fadiga e as análises ao sangue podem mostrar níveis de uma enzima que avalia a função muscular e cardíaca (enzima creatina cinase) aumentados. Em doentes com pressão arterial elevada e diabetes do tipo 2 com doença nos rins foram também notificados tonturas quando se passa da posição deitada ou sentada para a posição de pé, pressão arterial baixa quando se passa da posição deitada ou sentada para a posição de pé, dor nas articulações ou músculos e níveis de uma proteína nos glóbulos vermelhos (hemoglobina) diminuídos.</li><li>Pouco frequentes (podem afetar até 1 em 100 pessoas): ritmo cardíaco rápido, rubor (vermelhidão), tosse, diarreia, indigestão/pirose (azia), disfunção sexual (problemas com o desempenho sexual) e dor torácica.</li></ul><p>Alguns efeitos indesejáveis foram notificados desde a comercialização de Karvea. Os efeitos indesejáveis em que a frequência não é conhecida são: sensação de girar, cefaleias (dores de cabeça), alteração do paladar, zumbidos, cãimbras musculares, dor nas articulações e músculos, redução do número de glóbulos vermelhos (anemia - os sintomas podem incluir cansaço, dores de cabeça, falta de ar durante a prática de exercício físico, tonturas e aparência pálida), redução do número de plaquetas, função hepática (do fígado) alterada, níveis sanguíneos de potássio aumentados, compromisso da função dos rins e inflamação dos vasos sanguíneos pequenos afetando principalmente a pele (uma situação conhecida como vasculite leucocitoclásica) , reacções alérgicas graves (choque anafiláctico) e baixos níveis de açúcar no sangue. Foram também notificados casos pouco frequentes de icterícia (amarelecimento da pele e/ou da zona branca dos olhos).</p><p><strong>Comunicação de efeitos secundários</strong></p><p>Se tiver quaisquer efeitos secundários, incluindo possíveis efeitos secundários não indicados neste folheto, fale com o seu médico ou farmacêutico. Também poderá comunicar efeitos secundários diretamente através do sistema nacional de notificação mencionado no Apêndice V. Ao comunicar efeitos secundários, estará a ajudar a fornecer mais informações sobre a segurança deste medicamento.</p></div>
</text>
</section>
<section>
<title value="5. How to store Karvea"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="5. How to store Karvea"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>Manter este medicamento fora da vista e do alcance das crianças.</p><p>Não utilize este medicamento após o prazo de validade impresso na embalagem exterior e no blister, após VAL. O prazo de validade corresponde ao último dia do mês indicado.</p><p>Não conservar acima de 30ºC.</p><p>Não deite fora quaisquer medicamentos na canalização ou no lixo doméstico. Pergunte ao seu farmacêutico como deitar fora os medicamentos que já não necessita. Estas medidas ajudarão a proteger o ambiente.</p></div>
</text>
</section>
<section>
<title value="6. Contents of the pack and other information"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000155538"/>
</coding>
<text value="6. Contents of the pack and other information"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><strong>Qual a composição de Karvea</strong></p><ul><li>A substância ativa é o irbesartan. Cada comprimido de Karvea 300 mg contém 300 mg de irbesartan.</li><li>Os outros componentes são celulose microcristalina, croscarmelose sódica, lactose monohidratada, estearato de magnésio, sílica coloidal hidratada, amido de milho pré-gelificado e poloxamero 188. Por favor ver a secção 2 “Karvea contém lactose”.</li></ul><p><strong>Qual o aspeto de Karvea e conteúdo da embalagem</strong></p><p>Os comprimidos de Karvea 300 mg são de cor branca a esbranquiçada, biconvexos, de forma oval, com um coração marcado numa das faces e o número 2773 gravado na outra face.</p><p>Os comprimidos de Karvea a 300 mg são fornecidos em embalagens de 14, 28, 56 ou 98 comprimidos acondicionados em blister. Estão também disponíveis, para uso hospitalar, embalagens de 56 x 1 comprimido em blister para dose unitária.</p><p>É possível que não sejam comercializadas todas as apresentações.</p><p><strong>Titular da Autorização de Introdução no Mercado</strong> Sanofi Winthrop Industrie 82 avenue Raspail 94250 Gentilly França</p><p><strong>Fabricante</strong></p><p>SANOFI WINTHROP INDUSTRIE 1, rue de la Vierge Ambarès & Lagrave F-33565 Carbon Blanc Cedex - França</p><p>SANOFI WINTHROP INDUSTRIE 30-36 Avenue Gustave Eiffel, BP 7166 F-37071 Tours Cedex 2 - França</p><p>Para quaisquer informações sobre este medicamento, queira contactar o representante local do Titular da Autorização de Introdução no Mercado.</p><p><strong>België/Belgique/Belgien</strong> Sanofi Belgium Tél/Tel: +32 (0)2 710 54 00</p><p><strong>България</strong> Swixx Biopharma EOOD Тел.: +359 (0)2 4942 480</p><p><strong>Lietuva</strong> Swixx Biopharma UAB Tel: +370 5 236 91 40</p><p><strong>Luxembourg/Luxemburg</strong> Sanofi Belgium Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien)</p><p><strong>Česká republika</strong> sanofi-aventis, s.r.o. Tel: +420 233 086 111</p><p><strong>Magyarország</strong> SANOFI-AVENTIS Zrt. Tel.: +36 1 505 0050</p><p><strong>Danmark</strong> Sanofi A/S Tlf: +45 45 16 70 00</p><p><strong>Malta</strong> Sanofi S.r.l.. Tel: +39 02 39394275</p><p><strong>Deutschland</strong> Sanofi-Aventis Deutschland GmbH Tel: 0800 52 52 010 Tel. aus dem Ausland: +49 69 305 21 131</p><p><strong>Nederland</strong> Sanofi B.V. Tel: +31 20 245 4000</p><p><strong>Eesti</strong> Swixx Biopharma OÜ Tel: +372 640 10 30</p><p><strong>Norge</strong> sanofi-aventis Norge AS Tlf: +47 67 10 71 00</p><p><strong>Ελλάδα</strong> Sanofi-Aventis Μονοπρόσωπη AEBE Τηλ: +30 210 900 16 00</p><p><strong>Österreich</strong> sanofi-aventis GmbH Tel: +43 1 80 185 – 0</p><p><strong>España</strong> sanofi-aventis, S.A. Tel: +34 93 485 94 00</p><p><strong>Polska</strong> sanofi-aventis Sp. z o.o. Tel.: +48 22 280 00 00</p><p><strong>France</strong> Sanofi Winthrop Industrie Tél: 0 800 222 555 Appel depuis l’étranger : +33 1 57 63 23 23</p><p><strong>Portugal</strong> Sanofi - Produtos Farmacêuticos, Lda Tel: +351 21 35 89 400</p><p><strong>Hrvatska</strong> Swixx Biopharma d.o.o. Tel: +385 1 2078 500</p><p><strong>Ireland</strong> sanofi-aventis Ireland Ltd. Tel: +353 (0) 1 403 56 00</p><p><strong>România</strong> Sanofi Romania SRL Tel: +40 (0) 21 317 31 36</p><p><strong>Slovenija</strong> Swixx Biopharma d.o.o. Tel: +386 1 235 51 00</p><p><strong>Ísland</strong> Vistor hf. Sími: +354 535 7000</p><p><strong>Slovenská republika</strong> Swixx Biopharma s.r.o. Tel: +421 2 208 33 600</p><p><strong>Italia</strong> Sanofi S.r.l.Tel: 800536389</p><p><strong>Suomi/Finland</strong> Sanofi Oy Puh/Tel: +358 (0) 201 200 300</p><p><strong>Κύπρος</strong> C.A. Papaellinas Ltd. Τηλ: +357 22 741741</p><p><strong>Sverige</strong> Sanofi AB Tel: +46 (0)8 634 50 00</p><p><strong>Latvija</strong> Swixx Biopharma SIA Tel: +371 6 616 47 50</p><p><strong>United Kingdom (Northern Ireland)</strong> sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +44 (0) 800 035 2525</p><p><strong>Este folheto foi revisto pela última vez em</strong></p><p>Informação pormenorizada sobre este medicamento está disponível na Internet no site da Agência Europeia de Medicamentos <a href="http://www.ema.europa.eu/">http://www.ema.europa.eu/</a></p></div>
</text>
</section>
</section>
</Composition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/ClinicalUseDefinition/cud-a40c2367ed3c1c715eacd432105752a0"/>
<resource>
<ClinicalUseDefinition>
<id value="cud-a40c2367ed3c1c715eacd432105752a0"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-contraindication-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_cud-a40c2367ed3c1c715eacd432105752a0"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="cud-a40c2367ed3c1c715eacd432105752a0"> </a><a name="hccud-a40c2367ed3c1c715eacd432105752a0"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceClinicalUseDefinition "cud-a40c2367ed3c1c715eacd432105752a0" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-contraindication-uv-epi.html">ClinicalUseDefinition Contraindication (ePI)</a></p></div><p><b>type</b>: contraindication</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><blockquote><p><b>contraindication</b></p><h3>DiseaseSymptomProcedures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Diabetis Mellitus <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (mdr#10012601)</span></td></tr></table></blockquote></div>
</text>
<type value="contraindication"/>
<subject>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</subject>
<contraindication>
<diseaseSymptomProcedure>
<concept>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/mdr"/>
<code value="10012601"/>
<display value="Diabetis Mellitus"/>
</coding>
</concept>
</diseaseSymptomProcedure>
</contraindication>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/ClinicalUseDefinition/cud-585e364c14debe29f6c6b564138aa400"/>
<resource>
<ClinicalUseDefinition>
<id value="cud-585e364c14debe29f6c6b564138aa400"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-indication-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_cud-585e364c14debe29f6c6b564138aa400"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="cud-585e364c14debe29f6c6b564138aa400"> </a><a name="hccud-585e364c14debe29f6c6b564138aa400"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceClinicalUseDefinition "cud-585e364c14debe29f6c6b564138aa400" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-indication-uv-epi.html">ClinicalUseDefinition Indication (ePI)</a></p></div><p><b>type</b>: indication</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><blockquote><p><b>indication</b></p><h3>DiseaseSymptomProcedures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Hypertension <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (mdr#10020772)</span></td></tr></table></blockquote></div>
</text>
<type value="indication"/>
<subject>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</subject>
<indication>
<diseaseSymptomProcedure>
<concept>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/mdr"/>
<code value="10020772"/>
<display value="Hypertension"/>
</coding>
</concept>
</diseaseSymptomProcedure>
</indication>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/ClinicalUseDefinition/cud-4fce9d5258f70f7d605059f97c24efa8"/>
<resource>
<ClinicalUseDefinition>
<id value="cud-4fce9d5258f70f7d605059f97c24efa8"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_cud-4fce9d5258f70f7d605059f97c24efa8"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="cud-4fce9d5258f70f7d605059f97c24efa8"> </a><a name="hccud-4fce9d5258f70f7d605059f97c24efa8"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceClinicalUseDefinition "cud-4fce9d5258f70f7d605059f97c24efa8" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>type</b>: interaction</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>METHOTREXATE <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#YL5FZ2Y5U1)</span></td></tr></table></blockquote></div>
</text>
<type value="interaction"/>
<subject>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<code value="YL5FZ2Y5U1"/>
<display value="METHOTREXATE"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-hypromellose"/>
<resource>
<Ingredient>
<id value="ingredient-for-karvea-hypromellose"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredient-for-karvea-hypromellose"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-karvea-hypromellose"> </a><a name="hcingredient-for-karvea-hypromellose"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceIngredient "ingredient-for-karvea-hypromellose" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/3NXW29V3WO (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Hypromellose <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#3NXW29V3WO)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="3NXW29V3WO"/>
</identifier>
<status value="active"/>
<for>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<for>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</for>
<for>
<reference
value="AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="3NXW29V3WO"/>
<display value="Hypromellose"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-macrogol3000"/>
<resource>
<Ingredient>
<id value="ingredient-for-karvea-macrogol3000"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredient-for-karvea-macrogol3000"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-karvea-macrogol3000"> </a><a name="hcingredient-for-karvea-macrogol3000"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceIngredient "ingredient-for-karvea-macrogol3000" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/SA1B764746 (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Macrogol 3000 <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#SA1B764746)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="SA1B764746"/>
</identifier>
<status value="active"/>
<for>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<for>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</for>
<for>
<reference
value="AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="SA1B764746"/>
<display value="Macrogol 3000"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-lactosemonohydrate"/>
<resource>
<Ingredient>
<id value="ingredient-for-karvea-lactosemonohydrate"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredient-for-karvea-lactosemonohydrate"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-karvea-lactosemonohydrate"> </a><a name="hcingredient-for-karvea-lactosemonohydrate"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceIngredient "ingredient-for-karvea-lactosemonohydrate" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/EWQ57Q8I5X (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Lactose Monohydrate <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#EWQ57Q8I5X)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="EWQ57Q8I5X"/>
</identifier>
<status value="active"/>
<for>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<for>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</for>
<for>
<reference
value="AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="EWQ57Q8I5X"/>
<display value="Lactose Monohydrate"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-silicondioxide"/>
<resource>
<Ingredient>
<id value="ingredient-for-karvea-silicondioxide"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredient-for-karvea-silicondioxide"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-karvea-silicondioxide"> </a><a name="hcingredient-for-karvea-silicondioxide"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceIngredient "ingredient-for-karvea-silicondioxide" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/ETJ7Z6XBU4 (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Silicon dioxide <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#ETJ7Z6XBU4)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="ETJ7Z6XBU4"/>
</identifier>
<status value="active"/>
<for>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<for>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</for>
<for>
<reference
value="AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="ETJ7Z6XBU4"/>
<display value="Silicon dioxide"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-titaniumdioxide"/>
<resource>
<Ingredient>
<id value="ingredient-for-karvea-titaniumdioxide"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredient-for-karvea-titaniumdioxide"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-karvea-titaniumdioxide"> </a><a name="hcingredient-for-karvea-titaniumdioxide"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceIngredient "ingredient-for-karvea-titaniumdioxide" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/15FIX9V2JP (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Titanium Dioxide <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#15FIX9V2JP)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="15FIX9V2JP"/>
</identifier>
<status value="active"/>
<for>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<for>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</for>
<for>
<reference
value="AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="15FIX9V2JP"/>
<display value="Titanium Dioxide"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-irbesartan"/>
<resource>
<Ingredient>
<id value="ingredient-for-karvea-irbesartan"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredient-for-karvea-irbesartan"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-karvea-irbesartan"> </a><a name="hcingredient-for-karvea-irbesartan"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceIngredient "ingredient-for-karvea-irbesartan" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/J0E2756Z7N (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072072)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>irbesartan <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#J0E2756Z7N)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>75 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="J0E2756Z7N"/>
</identifier>
<status value="active"/>
<for>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<for>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</for>
<for>
<reference
value="AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072072"/>
<display value="active"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="J0E2756Z7N"/>
<display value="irbesartan"/>
</coding>
</concept>
</code>
<strength>
<presentationQuantity>
<value value="75"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</presentationQuantity>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
<display value="active ingredient - basis of strength"/>
</coding>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-croscarmellosesodium"/>
<resource>
<Ingredient>
<id value="ingredient-for-karvea-croscarmellosesodium"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredient-for-karvea-croscarmellosesodium"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-karvea-croscarmellosesodium"> </a><a name="hcingredient-for-karvea-croscarmellosesodium"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceIngredient "ingredient-for-karvea-croscarmellosesodium" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/M28OL1HH48 (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Croscarmellose sodium <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#M28OL1HH48)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="M28OL1HH48"/>
</identifier>
<status value="active"/>
<for>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<for>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</for>
<for>
<reference
value="AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="M28OL1HH48"/>
<display value="Croscarmellose sodium"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-microcrystallinecellulose"/>
<resource>
<Ingredient>
<id value="ingredient-for-karvea-microcrystallinecellulose"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredient-for-karvea-microcrystallinecellulose"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-karvea-microcrystallinecellulose"> </a><a name="hcingredient-for-karvea-microcrystallinecellulose"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceIngredient "ingredient-for-karvea-microcrystallinecellulose" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/OP1R32D61U (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Microcrystalline cellulose <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#OP1R32D61U)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="OP1R32D61U"/>
</identifier>
<status value="active"/>
<for>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<for>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</for>
<for>
<reference
value="AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="OP1R32D61U"/>
<display value="Microcrystalline cellulose"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-magnesiumstearate"/>
<resource>
<Ingredient>
<id value="ingredient-for-karvea-magnesiumstearate"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredient-for-karvea-magnesiumstearate"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-karvea-magnesiumstearate"> </a><a name="hcingredient-for-karvea-magnesiumstearate"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceIngredient "ingredient-for-karvea-magnesiumstearate" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/70097M6I30 (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Magnesium stearate <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#70097M6I30)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="70097M6I30"/>
</identifier>
<status value="active"/>
<for>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<for>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</for>
<for>
<reference
value="AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="70097M6I30"/>
<display value="Magnesium stearate"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-karvea-carnaubawax"/>
<resource>
<Ingredient>
<id value="ingredient-for-karvea-carnaubawax"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredient-for-karvea-carnaubawax"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredient-for-karvea-carnaubawax"> </a><a name="hcingredient-for-karvea-carnaubawax"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceIngredient "ingredient-for-karvea-carnaubawax" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/R12CBM0EIZ (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</li><li>See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</li><li>See on this page: AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Carnauba wax <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#R12CBM0EIZ)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="R12CBM0EIZ"/>
</identifier>
<status value="active"/>
<for>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<for>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</for>
<for>
<reference
value="AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="R12CBM0EIZ"/>
<display value="Carnauba wax"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/SubstanceDefinition/substance-irbesartan"/>
<resource>
<SubstanceDefinition>
<id value="substance-irbesartan"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="SubstanceDefinition_substance-irbesartan"> </a><p><b>Generated Narrative: SubstanceDefinition</b><a name="substance-irbesartan"> </a><a name="hcsubstance-irbesartan"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceSubstanceDefinition "substance-irbesartan" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-SubstanceDefinition-uv-epi.html">SubstanceDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta/</code>/J0E2756Z7N (use: official)</p><p><b>version</b>: 1</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>description</b>: White to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2771 engraved on the other side.</p><p><b>manufacturer</b>: See on this page: Organization/mah-511671db37e83e520b00f8a0d817dc96</p><h3>MolecularWeights</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Amount</b></td></tr><tr><td style="display: none">*</td><td>exact <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span></td><td>428.53</td></tr></table><h3>Structures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>MolecularFormula</b></td></tr><tr><td style="display: none">*</td><td>C25H28N6O</td></tr></table><h3>Names</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Name</b></td><td><b>Type</b></td></tr><tr><td style="display: none">*</td><td>(+)-6-methyleneandrosta-1,4-diene-3,17-dione</td><td>Chemical Name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#x)</span></td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<value value="J0E2756Z7N"/>
</identifier>
<version value="1"/>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
</coding>
</status>
<description
value="White to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2771 engraved on the other side."/>
<manufacturer>
<reference
value="Organization/mah-511671db37e83e520b00f8a0d817dc96"/>
</manufacturer>
<molecularWeight>
<type>
<text value="exact"/>
</type>
<amount>
<value value="428.53"/>
</amount>
</molecularWeight>
<structure>
<molecularFormula value="C25H28N6O"/>
</structure>
<name>
<name value="(+)-6-methyleneandrosta-1,4-diene-3,17-dione"/>
<type>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<code value="x"/>
<display value="Chemical Name"/>
</coding>
</type>
</name>
</SubstanceDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/AdministrableProductDefinition/ap-dcaa4d32aa6658a8df831551503e52ee"/>
<resource>
<AdministrableProductDefinition>
<id value="ap-dcaa4d32aa6658a8df831551503e52ee"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="AdministrableProductDefinition_ap-dcaa4d32aa6658a8df831551503e52ee"> </a><p><b>Generated Narrative: AdministrableProductDefinition</b><a name="ap-dcaa4d32aa6658a8df831551503e52ee"> </a><a name="hcap-dcaa4d32aa6658a8df831551503e52ee"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceAdministrableProductDefinition "ap-dcaa4d32aa6658a8df831551503e52ee" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-AdministrableProductDefinition-uv-epi.html">AdministrableProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/001</p><p><b>status</b>: active</p><p><b>formOf</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><p><b>administrableDoseForm</b>: Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073664)</span></p><p><b>unitOfPresentation</b>: Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002152)</span></p><p><b>producedFrom</b>: See on this page: ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee</p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Oral use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073619)</span></p><h3>TargetSpecies</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td>Human <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000109093)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="EU/1/97/049/001"/>
</identifier>
<status value="active"/>
<formOf>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</formOf>
<administrableDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073664"/>
<display value="Tablet"/>
</coding>
</administrableDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000002152"/>
<display value="Tablet"/>
</coding>
</unitOfPresentation>
<producedFrom>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</producedFrom>
<routeOfAdministration>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073619"/>
<display value="Oral use"/>
</coding>
</code>
<targetSpecies>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000109093"/>
<display value="Human"/>
</coding>
</code>
</targetSpecies>
</routeOfAdministration>
</AdministrableProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorizationdcaa4d32aa6658a8df831551503e52ee0"/>
<resource>
<RegulatedAuthorization>
<id value="authorizationdcaa4d32aa6658a8df831551503e52ee0"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_authorizationdcaa4d32aa6658a8df831551503e52ee0"> </a><p><b>Generated Narrative: RegulatedAuthorization</b><a name="authorizationdcaa4d32aa6658a8df831551503e52ee0"> </a><a name="hcauthorizationdcaa4d32aa6658a8df831551503e52ee0"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceRegulatedAuthorization "authorizationdcaa4d32aa6658a8df831551503e52ee0" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/010 (use: official)</p><p><b>subject</b>: See on this page: PackagedProductDefinition/ppd-d91b269b209aaa5538a1bfafd1a7434d</p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000061)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>holder</b>: See on this page: Organization/mah-511671db37e83e520b00f8a0d817dc96</p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="EU/1/97/049/010"/>
</identifier>
<subject>
<reference
value="PackagedProductDefinition/ppd-d91b269b209aaa5538a1bfafd1a7434d"/>
</subject>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000061"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2015-02-07T13:28:17Z"/>
<holder>
<reference
value="Organization/mah-511671db37e83e520b00f8a0d817dc96"/>
</holder>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorizationdcaa4d32aa6658a8df831551503e52ee1"/>
<resource>
<RegulatedAuthorization>
<id value="authorizationdcaa4d32aa6658a8df831551503e52ee1"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_authorizationdcaa4d32aa6658a8df831551503e52ee1"> </a><p><b>Generated Narrative: RegulatedAuthorization</b><a name="authorizationdcaa4d32aa6658a8df831551503e52ee1"> </a><a name="hcauthorizationdcaa4d32aa6658a8df831551503e52ee1"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceRegulatedAuthorization "authorizationdcaa4d32aa6658a8df831551503e52ee1" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/001 (use: official)</p><p><b>subject</b>: See on this page: PackagedProductDefinition/ppd-f3f2f89544dfc5d20216861bcf90c0c5</p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000061)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>holder</b>: See on this page: Organization/mah-511671db37e83e520b00f8a0d817dc96</p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="EU/1/97/049/001"/>
</identifier>
<subject>
<reference
value="PackagedProductDefinition/ppd-f3f2f89544dfc5d20216861bcf90c0c5"/>
</subject>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000061"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2015-02-07T13:28:17Z"/>
<holder>
<reference
value="Organization/mah-511671db37e83e520b00f8a0d817dc96"/>
</holder>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorizationdcaa4d32aa6658a8df831551503e52ee2"/>
<resource>
<RegulatedAuthorization>
<id value="authorizationdcaa4d32aa6658a8df831551503e52ee2"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_authorizationdcaa4d32aa6658a8df831551503e52ee2"> </a><p><b>Generated Narrative: RegulatedAuthorization</b><a name="authorizationdcaa4d32aa6658a8df831551503e52ee2"> </a><a name="hcauthorizationdcaa4d32aa6658a8df831551503e52ee2"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceRegulatedAuthorization "authorizationdcaa4d32aa6658a8df831551503e52ee2" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/002 (use: official)</p><p><b>subject</b>: See on this page: PackagedProductDefinition/ppd-5763619e2b501aeeab53677bd09d5cbf</p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000061)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>holder</b>: See on this page: Organization/mah-511671db37e83e520b00f8a0d817dc96</p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="EU/1/97/049/002"/>
</identifier>
<subject>
<reference
value="PackagedProductDefinition/ppd-5763619e2b501aeeab53677bd09d5cbf"/>
</subject>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000061"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2015-02-07T13:28:17Z"/>
<holder>
<reference
value="Organization/mah-511671db37e83e520b00f8a0d817dc96"/>
</holder>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorizationdcaa4d32aa6658a8df831551503e52ee3"/>
<resource>
<RegulatedAuthorization>
<id value="authorizationdcaa4d32aa6658a8df831551503e52ee3"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_authorizationdcaa4d32aa6658a8df831551503e52ee3"> </a><p><b>Generated Narrative: RegulatedAuthorization</b><a name="authorizationdcaa4d32aa6658a8df831551503e52ee3"> </a><a name="hcauthorizationdcaa4d32aa6658a8df831551503e52ee3"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceRegulatedAuthorization "authorizationdcaa4d32aa6658a8df831551503e52ee3" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/003 (use: official)</p><p><b>subject</b>: See on this page: PackagedProductDefinition/ppd-9b1d5d261d22694685deb35714ec08ea</p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000061)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>holder</b>: See on this page: Organization/mah-511671db37e83e520b00f8a0d817dc96</p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="EU/1/97/049/003"/>
</identifier>
<subject>
<reference
value="PackagedProductDefinition/ppd-9b1d5d261d22694685deb35714ec08ea"/>
</subject>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000061"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2015-02-07T13:28:17Z"/>
<holder>
<reference
value="Organization/mah-511671db37e83e520b00f8a0d817dc96"/>
</holder>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Organization/mah-511671db37e83e520b00f8a0d817dc96"/>
<resource>
<Organization>
<id value="mah-511671db37e83e520b00f8a0d817dc96"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Organization_mah-511671db37e83e520b00f8a0d817dc96"> </a><p><b>Generated Narrative: Organization</b><a name="mah-511671db37e83e520b00f8a0d817dc96"> </a><a name="hcmah-511671db37e83e520b00f8a0d817dc96"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceOrganization "mah-511671db37e83e520b00f8a0d817dc96" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Organization-uv-epi.html">Organization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/omswi</code>/ORG-100011564 (use: official)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000034)</span></p><p><b>name</b>: Sanofi Winthrop Industrie </p><h3>Contacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Address</b></td></tr><tr><td style="display: none">*</td><td>82 avenue Raspail Gentilly FR(work)</td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/omswi"/>
<value value="ORG-100011564"/>
</identifier>
<active value="true"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000034"/>
<display value="Marketing authorisation holder"/>
</coding>
</type>
<name value="Sanofi Winthrop Industrie "/>
<contact>
<address>
<use value="work"/>
<type value="physical"/>
<text value="82 avenue Raspail Gentilly FR"/>
<line value="82 avenue Raspail"/>
<city value="Gentilly"/>
<postalCode value="94250"/>
<country value="FR"/>
</address>
</contact>
</Organization>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/Organization/man-4bb7a752921434fd5f9921b5b9473eda"/>
<resource>
<Organization>
<id value="man-4bb7a752921434fd5f9921b5b9473eda"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Organization_man-4bb7a752921434fd5f9921b5b9473eda"> </a><p><b>Generated Narrative: Organization</b><a name="man-4bb7a752921434fd5f9921b5b9473eda"> </a><a name="hcman-4bb7a752921434fd5f9921b5b9473eda"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceOrganization "man-4bb7a752921434fd5f9921b5b9473eda" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Organization-uv-epi.html">Organization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/omswi</code>/ORG-100011564 (use: official)</p><p><b>active</b>: true</p><p><b>type</b>: Manufacturer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000033)</span></p><p><b>name</b>: Sanofi Winthrop Industrie</p><h3>Contacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Address</b></td></tr><tr><td style="display: none">*</td><td>1, rue de la Vierge Ambarès & Lagrave FR(work)</td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/omswi"/>
<value value="ORG-100011564"/>
</identifier>
<active value="true"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000033"/>
<display value="Manufacturer"/>
</coding>
</type>
<name value="Sanofi Winthrop Industrie"/>
<contact>
<address>
<use value="work"/>
<type value="physical"/>
<text value="1, rue de la Vierge Ambarès & Lagrave FR"/>
<line value="1, rue de la Vierge"/>
<city value="Ambarès & Lagrave"/>
<postalCode value="33565"/>
<country value="FR"/>
</address>
</contact>
</Organization>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-d91b269b209aaa5538a1bfafd1a7434d"/>
<resource>
<PackagedProductDefinition>
<id value="ppd-d91b269b209aaa5538a1bfafd1a7434d"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_ppd-d91b269b209aaa5538a1bfafd1a7434d"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd-d91b269b209aaa5538a1bfafd1a7434d"> </a><a name="hcppd-d91b269b209aaa5538a1bfafd1a7434d"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourcePackagedProductDefinition "ppd-d91b269b209aaa5538a1bfafd1a7434d" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/010 (use: official)</p><p><b>name</b>: Karvea 75 mg tablet 14</p><p><b>type</b>: Chemical Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>containedItemQuantity</b>: 75 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/man-4bb7a752921434fd5f9921b5b9473eda</p><blockquote><p><b>packaging</b></p><p><b>type</b>: Box <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073498)</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: Cardboard <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003529)</span></p><blockquote><p><b>packaging</b></p><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/123456</p><p><b>type</b>: Blister <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073496)</span></p><p><b>quantity</b>: 14</p><p><b>material</b>: PolyVinyl Chloride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003222)</span></p><blockquote><p><b>containedItem</b></p></blockquote></blockquote></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="EU/1/97/049/010"/>
</identifier>
<name value="Karvea 75 mg tablet 14"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000155527"/>
<display value="Chemical Medicinal Product"/>
</coding>
</type>
<packageFor>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</packageFor>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2015-02-07T13:28:17Z"/>
<containedItemQuantity>
<value value="75"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</containedItemQuantity>
<manufacturer>
<reference
value="Organization/man-4bb7a752921434fd5f9921b5b9473eda"/>
</manufacturer>
<packaging>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073498"/>
<display value="Box"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003529"/>
<display value="Cardboard"/>
</coding>
</material>
<packaging>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="123456"/>
</identifier>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073496"/>
<display value="Blister"/>
</coding>
</type>
<quantity value="14"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003222"/>
<display value="PolyVinyl Chloride"/>
</coding>
</material>
<containedItem>
<item>
<reference>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</reference>
</item>
</containedItem>
</packaging>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-f3f2f89544dfc5d20216861bcf90c0c5"/>
<resource>
<PackagedProductDefinition>
<id value="ppd-f3f2f89544dfc5d20216861bcf90c0c5"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_ppd-f3f2f89544dfc5d20216861bcf90c0c5"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd-f3f2f89544dfc5d20216861bcf90c0c5"> </a><a name="hcppd-f3f2f89544dfc5d20216861bcf90c0c5"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourcePackagedProductDefinition "ppd-f3f2f89544dfc5d20216861bcf90c0c5" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/001 (use: official)</p><p><b>name</b>: Karvea 75 mg tablet 28</p><p><b>type</b>: Chemical Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>containedItemQuantity</b>: 75 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/man-4bb7a752921434fd5f9921b5b9473eda</p><blockquote><p><b>packaging</b></p><p><b>type</b>: Box <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073498)</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: Cardboard <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003529)</span></p><blockquote><p><b>packaging</b></p><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/123456</p><p><b>type</b>: Blister <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073496)</span></p><p><b>quantity</b>: 28</p><p><b>material</b>: PolyVinyl Chloride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003222)</span></p><blockquote><p><b>containedItem</b></p></blockquote></blockquote></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="EU/1/97/049/001"/>
</identifier>
<name value="Karvea 75 mg tablet 28"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000155527"/>
<display value="Chemical Medicinal Product"/>
</coding>
</type>
<packageFor>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</packageFor>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2015-02-07T13:28:17Z"/>
<containedItemQuantity>
<value value="75"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</containedItemQuantity>
<manufacturer>
<reference
value="Organization/man-4bb7a752921434fd5f9921b5b9473eda"/>
</manufacturer>
<packaging>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073498"/>
<display value="Box"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003529"/>
<display value="Cardboard"/>
</coding>
</material>
<packaging>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="123456"/>
</identifier>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073496"/>
<display value="Blister"/>
</coding>
</type>
<quantity value="28"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003222"/>
<display value="PolyVinyl Chloride"/>
</coding>
</material>
<containedItem>
<item>
<reference>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</reference>
</item>
</containedItem>
</packaging>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-5763619e2b501aeeab53677bd09d5cbf"/>
<resource>
<PackagedProductDefinition>
<id value="ppd-5763619e2b501aeeab53677bd09d5cbf"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_ppd-5763619e2b501aeeab53677bd09d5cbf"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd-5763619e2b501aeeab53677bd09d5cbf"> </a><a name="hcppd-5763619e2b501aeeab53677bd09d5cbf"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourcePackagedProductDefinition "ppd-5763619e2b501aeeab53677bd09d5cbf" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/002 (use: official)</p><p><b>name</b>: Karvea 75 mg tablet 56</p><p><b>type</b>: Chemical Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>containedItemQuantity</b>: 75 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/man-4bb7a752921434fd5f9921b5b9473eda</p><blockquote><p><b>packaging</b></p><p><b>type</b>: Box <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073498)</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: Cardboard <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003529)</span></p><blockquote><p><b>packaging</b></p><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/123456</p><p><b>type</b>: Blister <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073496)</span></p><p><b>quantity</b>: 56</p><p><b>material</b>: PolyVinyl Chloride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003222)</span></p><blockquote><p><b>containedItem</b></p></blockquote></blockquote></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="EU/1/97/049/002"/>
</identifier>
<name value="Karvea 75 mg tablet 56"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000155527"/>
<display value="Chemical Medicinal Product"/>
</coding>
</type>
<packageFor>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</packageFor>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2015-02-07T13:28:17Z"/>
<containedItemQuantity>
<value value="75"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</containedItemQuantity>
<manufacturer>
<reference
value="Organization/man-4bb7a752921434fd5f9921b5b9473eda"/>
</manufacturer>
<packaging>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073498"/>
<display value="Box"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003529"/>
<display value="Cardboard"/>
</coding>
</material>
<packaging>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="123456"/>
</identifier>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073496"/>
<display value="Blister"/>
</coding>
</type>
<quantity value="56"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003222"/>
<display value="PolyVinyl Chloride"/>
</coding>
</material>
<containedItem>
<item>
<reference>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</reference>
</item>
</containedItem>
</packaging>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-9b1d5d261d22694685deb35714ec08ea"/>
<resource>
<PackagedProductDefinition>
<id value="ppd-9b1d5d261d22694685deb35714ec08ea"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_ppd-9b1d5d261d22694685deb35714ec08ea"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd-9b1d5d261d22694685deb35714ec08ea"> </a><a name="hcppd-9b1d5d261d22694685deb35714ec08ea"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourcePackagedProductDefinition "ppd-9b1d5d261d22694685deb35714ec08ea" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/003 (use: official)</p><p><b>name</b>: Karvea 75 mg tablet 98</p><p><b>type</b>: Chemical Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>containedItemQuantity</b>: 75 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/man-4bb7a752921434fd5f9921b5b9473eda</p><blockquote><p><b>packaging</b></p><p><b>type</b>: Box <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073498)</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: Cardboard <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003529)</span></p><blockquote><p><b>packaging</b></p><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/123456</p><p><b>type</b>: Blister <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073496)</span></p><p><b>quantity</b>: 98</p><p><b>material</b>: PolyVinyl Chloride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003222)</span></p><blockquote><p><b>containedItem</b></p></blockquote></blockquote></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="EU/1/97/049/003"/>
</identifier>
<name value="Karvea 75 mg tablet 98"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000155527"/>
<display value="Chemical Medicinal Product"/>
</coding>
</type>
<packageFor>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</packageFor>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2015-02-07T13:28:17Z"/>
<containedItemQuantity>
<value value="75"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</containedItemQuantity>
<manufacturer>
<reference
value="Organization/man-4bb7a752921434fd5f9921b5b9473eda"/>
</manufacturer>
<packaging>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073498"/>
<display value="Box"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003529"/>
<display value="Cardboard"/>
</coding>
</material>
<packaging>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="123456"/>
</identifier>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073496"/>
<display value="Blister"/>
</coding>
</type>
<quantity value="98"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003222"/>
<display value="PolyVinyl Chloride"/>
</coding>
</material>
<containedItem>
<item>
<reference>
<reference
value="ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
</reference>
</item>
</containedItem>
</packaging>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
<resource>
<MedicinalProductDefinition>
<id value="mp873a1a47330e628770640f9c96c0761e"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicinalProductDefinition_mp873a1a47330e628770640f9c96c0761e"> </a><p><b>Generated Narrative: MedicinalProductDefinition</b><a name="mp873a1a47330e628770640f9c96c0761e"> </a><a name="hcmp873a1a47330e628770640f9c96c0761e"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceMedicinalProductDefinition "mp873a1a47330e628770640f9c96c0761e" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-MedicinalProductDefinition-uv-epi.html">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/001, <code>https://www.who-umc.org/phpid</code>/0xF79CABF272B6A7EEF104DDDA44E82719</p><p><b>type</b>: Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-type.html">Medicinal Product Type</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-domain.html">Medicinal Product Domain</a>#Human)</span></p><p><b>status</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Karvea 75 mg tablet</p><p><b>type</b>: Full name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000001)</span></p><blockquote><p><b>part</b></p><p><b>part</b>: Karvea</p><p><b>type</b>: Invented name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000002)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: irbesartan</p><p><b>type</b>: Scientific name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000003)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 75 mg</p><p><b>type</b>: Strength part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000004)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: tablet</p><p><b>type</b>: Pharmaceutical dose form part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000005)</span></p></blockquote><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td>Denmark <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#DK)</span></td><td>Denmark <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#DK)</span></td><td>English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="EU/1/97/049/001"/>
</identifier>
<identifier>
<system value="https://www.who-umc.org/phpid"/>
<value value="0xF79CABF272B6A7EEF104DDDA44E82719"/>
</identifier>
<type>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-type"/>
<code value="MedicinalProduct"/>
<display value="Medicinal Product"/>
</coding>
</type>
<domain>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-domain"/>
<code value="Human"/>
<display value="Human use"/>
</coding>
</domain>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="active"/>
</coding>
</status>
<legalStatusOfSupply>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072084"/>
<display
value="Medicinal product subject to medical prescription"/>
</coding>
</legalStatusOfSupply>
<name>
<productName value="Karvea 75 mg tablet"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000001"/>
<display value="Full name"/>
</coding>
</type>
<part>
<part value="Karvea"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000002"/>
<display value="Invented name part"/>
</coding>
</type>
</part>
<part>
<part value="irbesartan"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000003"/>
<display value="Scientific name part"/>
</coding>
</type>
</part>
<part>
<part value="75 mg"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000004"/>
<display value="Strength part"/>
</coding>
</type>
</part>
<part>
<part value="tablet"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000005"/>
<display value="Pharmaceutical dose form part"/>
</coding>
</type>
</part>
<usage>
<country>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="DK"/>
<display value="Denmark"/>
</coding>
</country>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="DK"/>
<display value="Denmark"/>
</coding>
</jurisdiction>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
</usage>
</name>
</MedicinalProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/mid-dcaa4d32aa6658a8df831551503e52ee"/>
<resource>
<ManufacturedItemDefinition>
<id value="mid-dcaa4d32aa6658a8df831551503e52ee"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ManufacturedItemDefinition_mid-dcaa4d32aa6658a8df831551503e52ee"> </a><p><b>Generated Narrative: ManufacturedItemDefinition</b><a name="mid-dcaa4d32aa6658a8df831551503e52ee"> </a><a name="hcmid-dcaa4d32aa6658a8df831551503e52ee"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceManufacturedItemDefinition "mid-dcaa4d32aa6658a8df831551503e52ee" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ManufacturedItemDefinition-uv-epi.html">ManufacturedItemDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/EU/1/97/049/001 (use: official)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000073664)</span></p><p><b>unitOfPresentation</b>: Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002152)</span></p><p><b>manufacturer</b>: See on this page: Organization/man-4bb7a752921434fd5f9921b5b9473eda</p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="EU/1/97/049/001"/>
</identifier>
<status value="active"/>
<manufacturedDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000073664"/>
<display value="Tablet"/>
</coding>
</manufacturedDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000002152"/>
<display value="Tablet"/>
</coding>
</unitOfPresentation>
<manufacturer>
<reference
value="Organization/man-4bb7a752921434fd5f9921b5b9473eda"/>
</manufacturer>
</ManufacturedItemDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/ClinicalUseDefinition/contraindication-kidney"/>
<resource>
<ClinicalUseDefinition>
<id value="contraindication-kidney"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-contraindication-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_contraindication-kidney"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="contraindication-kidney"> </a><a name="hccontraindication-kidney"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceClinicalUseDefinition "contraindication-kidney" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-contraindication-uv-epi.html">ClinicalUseDefinition Contraindication (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/rmswi/#/</code>/kidney function (use: official)</p><p><b>type</b>: contraindication</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><blockquote><p><b>contraindication</b></p><h3>DiseaseSymptomProcedures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Decreased renal function (finding) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOWMED CT</a>#76114004)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/rmswi/#/"/>
<value value="kidney function"/>
</identifier>
<type value="contraindication"/>
<subject>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</subject>
<contraindication>
<diseaseSymptomProcedure>
<concept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="76114004"/>
<display value="Decreased renal function (finding)"/>
</coding>
</concept>
</diseaseSymptomProcedure>
</contraindication>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/ClinicalUseDefinition/contraindication-diabetes-mellitus"/>
<resource>
<ClinicalUseDefinition>
<id value="contraindication-diabetes-mellitus"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-contraindication-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_contraindication-diabetes-mellitus"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="contraindication-diabetes-mellitus"> </a><a name="hccontraindication-diabetes-mellitus"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceClinicalUseDefinition "contraindication-diabetes-mellitus" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-contraindication-uv-epi.html">ClinicalUseDefinition Contraindication (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/rmswi/#/</code>/diabetes-mellitus (use: official)</p><p><b>type</b>: contraindication</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><blockquote><p><b>contraindication</b></p><h3>DiseaseSymptomProcedures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Diabetes mellitus (disorder) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOWMED CT</a>#73211009)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/rmswi/#/"/>
<value value="diabetes-mellitus"/>
</identifier>
<type value="contraindication"/>
<subject>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</subject>
<contraindication>
<diseaseSymptomProcedure>
<concept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="73211009"/>
<display value="Diabetes mellitus (disorder)"/>
</coding>
</concept>
</diseaseSymptomProcedure>
</contraindication>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://hl7.eu/fhir/ig/gravitate-health/ClinicalUseDefinition/contraindication-pregnancy"/>
<resource>
<ClinicalUseDefinition>
<id value="contraindication-pregnancy"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-contraindication-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_contraindication-pregnancy"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="contraindication-pregnancy"> </a><a name="hccontraindication-pregnancy"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceClinicalUseDefinition "contraindication-pregnancy" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-contraindication-uv-epi.html">ClinicalUseDefinition Contraindication (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/rmswi/#/</code>/pregnancy (use: official)</p><p><b>type</b>: contraindication</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e</p><blockquote><p><b>contraindication</b></p><h3>DiseaseSymptomProcedures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>Pregnancy, function (observable entity) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOWMED CT</a>#289908002)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/rmswi/#/"/>
<value value="pregnancy"/>
</identifier>
<type value="contraindication"/>
<subject>
<reference
value="MedicinalProductDefinition/mp873a1a47330e628770640f9c96c0761e"/>
</subject>
<contraindication>
<diseaseSymptomProcedure>
<concept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="289908002"/>
<display value="Pregnancy, function (observable entity)"/>
</coding>
</concept>
</diseaseSymptomProcedure>
</contraindication>
</ClinicalUseDefinition>
</resource>
</entry>
</Bundle>
IG © 2021+ Gravitate Health Project. Package hl7.eu.fhir.gh#0.1.0 based on FHIR 5.0.0. Generated 2024-05-15
Links: Table of Contents |
QA Report
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.
